Tag Archives: Pulmonary

Response to Inhaled NO in Neonates With Persistent Pulmonary Hypertension Varies

February 08, 2019 This article originally appeared here. Share this content: More patients in the inhaled nitric oxide group had improved oxygenation without needing extracorporeal membrane oxygenation compared with patients who received placebo. Increases and decreases in partial pressure of arterial oxygen (PaO2) and oxygenation index (OI) after the initiation of inhaled nitric oxide (iNO)… Read More »

FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD)

FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD) Print this page DUBLIN, Ireland, HERTFORDSHIRE, England and PITTSBURGH, Nov. 9, 2018 /PRNewswire/ — Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma”) and Mylan N.V. (NASDAQ: MYL) (“Mylan”) today announced that the U.S. Food and Drug Administration (FDA) has approved the  New Drug Application (NDA) for… Read More »